Skip to content

Complimentary Corporate Symposium: Significance Beyond Statistics: Redefining the P-Value

Saturday, March 2 • 11:00 AM – 12:30 PM ET

In Person_Virtual

Register for the virtual stream here.

SUPPORT ACKNOWLEDGEMENT 
Thanks in part to a generous education grant from Takeda

PROGRAM DESCRIPTION
Can we rethink the p-value where p stands for patient? What matters to patients on long-term nutrition support therapy? What are some of the biggest struggles and challenges from the patient point of view? What are significant differences to patients? Presented by the Oley Foundation.

LEARNING OBJECTIVES

  1. Identify meaningful differences to patients on long-term nutrition support therapy while addressing barriers to access to connect patients with devices, therapy, team and community.
  2. Understand the significance of nuanced patient outcomes in research and innovation such as GLP2s.
  3. Articulate the patient perspective on the value of being connected to clinicians who are experts in the field while also being heard and considered a valuable member of the team.


FACULTY

Kelly Tappenden, PhD, RD, FASPEN
Andrea Taylor, RD, CNSC
Shelley Chalmers
Vanessa Kumpf, PharmD, BCNSP, FASPEN
Vince Rosche
Zoe Gore
Beth Gore, PhD

Sponsored by

Takeda